Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 71335-2449

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 71335-2449). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Esome-structure (Esome Structure)

Esome-structure (Esome Structure)
Chemical structure of esomeprazole magnesium showing the molecular arrangement including methoxy groups, sulfur, nitrogen atoms, and magnesium ion complexed with three water molecules (Mg2+ ยท 3 H2O).*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A line graph depicting the percent maintained over six months across different treatment groups: Esomeprazole Magnesium 40 mg, 20 mg, 10 mg, and placebo. The y-axis represents percent maintained from 0 to 100, and the x-axis shows months with scheduled visits labeled as 'S'. Each group is represented by a different line style and marker.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A line chart showing the percent of subjects maintaining a measurement over 6 months for esomeprazole magnesium at doses 40 mg, 20 mg, 10 mg, and placebo. The y-axis represents percent maintained, ranging from 0 to 100, and the x-axis shows months with scheduled visits. The 40 mg dose maintains close to 100%, while lower doses and placebo show decreasing percentages over time.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
A line graph showing the percent of patients symptom-free over a 28-day diary period. It compares Esomeprazole Magnesium delayed-release capsules at 40 mg and 20 mg doses versus placebo, illustrating the improvement in symptom-free percentage over time for both doses compared to placebo.*
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
A line graph showing the percent of patients symptom-free over a 28-day diary period. The graph compares Esomeprazole Magnesium Delayed-Release Capsules at 40 mg, 20 mg doses, and a placebo, with percent patients symptom-free on the y-axis and diary days on the x-axis.*
FDA Label Image

Label (Lbl713352449)

Label (Lbl713352449)
Label for Esomeprazole Magnesium delayed-release capsules, USP, 40 mg strength. The label shows the product NDC 71335-2449-1 and indicates 90 capsules per container. It is repackaged by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Granules India Limited. Storage instructions and dosage information are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.